Cataract Surgery Devices Market -Global Trends and Forecasts(2025 to 2034)
Description
Cataract Surgery Devices Market Size And Forecast
According to Factview Research, the Cataract Surgery Devices Market was valued at USD 3.39 Billion in 2024 and is projected to reach USD 5.33 Billion by 2034, growing at a CAGR of 5.1% from 2025 to 2034.
Global Cataract Surgery Devices Market Outlook
Growing incidences of ocular disorders, increasing geriatric population are major factors expected to fuel the growth of the Global cataract surgery devices market. According to All About Vision Media, A National Supporter and Sponsor of Optometry Giving Sight, cataract is the primary cause of blindness across the globe affecting almost 22 million Americans aged 40 and above and the number is expected to rise to 30 million by the end of 2020. Moreover, product innovation and evolution by new entrants expected to propel the market growth. For instance, in March 2016, Mynosys Cellular Devices, Inc., a private company invented a unique cataract surgery device known as Zepto, that provides high precision, accuracy, and safety in reproducible capsulotomy. However, the high costs of cataract surgeries in developing economies, lack of healthcare insurance, and less awareness among individuals regarding the benefits of cataract surgeries are the key factors that might stagnate the market growth. Furthermore, the governments introduce programs to decrease the burden of cataract related diseases, create lucrative opportunities for key players.
Global Cataract Surgery Devices Market Competitive Landscape
The Global Cataract Surgery Devices Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Carl Zeiss Meditech AG, Bausch & Lomb, Inc., Abbott Laboratories, NIDEK Co., Ltd, Allergen, Inc., Alcon, Inc., STAAR Surgical Company, Opcon Corporation, and Essilor International S.A.
According to Factview Research, the Cataract Surgery Devices Market was valued at USD 3.39 Billion in 2024 and is projected to reach USD 5.33 Billion by 2034, growing at a CAGR of 5.1% from 2025 to 2034.
Global Cataract Surgery Devices Market Outlook
Growing incidences of ocular disorders, increasing geriatric population are major factors expected to fuel the growth of the Global cataract surgery devices market. According to All About Vision Media, A National Supporter and Sponsor of Optometry Giving Sight, cataract is the primary cause of blindness across the globe affecting almost 22 million Americans aged 40 and above and the number is expected to rise to 30 million by the end of 2020. Moreover, product innovation and evolution by new entrants expected to propel the market growth. For instance, in March 2016, Mynosys Cellular Devices, Inc., a private company invented a unique cataract surgery device known as Zepto, that provides high precision, accuracy, and safety in reproducible capsulotomy. However, the high costs of cataract surgeries in developing economies, lack of healthcare insurance, and less awareness among individuals regarding the benefits of cataract surgeries are the key factors that might stagnate the market growth. Furthermore, the governments introduce programs to decrease the burden of cataract related diseases, create lucrative opportunities for key players.
Global Cataract Surgery Devices Market Competitive Landscape
The Global Cataract Surgery Devices Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Carl Zeiss Meditech AG, Bausch & Lomb, Inc., Abbott Laboratories, NIDEK Co., Ltd, Allergen, Inc., Alcon, Inc., STAAR Surgical Company, Opcon Corporation, and Essilor International S.A.
Table of Contents
186 Pages
- 1 Introduction Of Global Cataract Surgery Devices Market
- 1.1 Overview Of The Market
- 1.2 Scope Of Report
- 1.3 Assumptions
- 2 Executive Summary
- 3 Research Methodology Of Factview Research
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List Of Data Sources
- 4 Global Cataract Surgery Devices Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Cataract Surgery Devices Market, By Product
- 5.1 Overview
- 5.2 Intraocular Lens (Iol)
- 5.3 Ophthalmic Viscoelastic Device (Ovd)
- 5.4 Femtosecond Laser Equipment
- 5.5 Phacoemulsification Equipment
- 6 Global Cataract Surgery Devices Market, By End-user
- 6.1 Overview
- 6.2 Hospitals And Clinics
- 6.3 Ophthalmology Centers
- 7 Global Cataract Surgery Devices Market, By Geography
- 7.1 Overview
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest Of Europe
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest Of Asia Pacific
- 7.5 Rest Of The World
- 7.5.1 Latin America
- 7.5.2 Middle East
- 8 Global Cataract Surgery Devices Market Competitive Landscape
- 8.1 Overview
- 8.2 Company Market Ranking
- 8.3 Key Development Strategies
- 9 Company Profiles
- 9.1 Carl Zeiss Meditech Ag
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
- 9.2 Bausch &Amp; Lomb, Inc.
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
- 9.3 Abbott Laboratories
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
- 9.4 Nidek Co., Ltd
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
- 9.5 Allergen, Inc.
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
- 9.6 Alcon, Inc.
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
- 9.7 Staar Surgical Company
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
- 9.8 Opcon Corporation
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
- 9.9 Essilor International S.A.
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
- 10 Appendix
- 10.1 Related Research
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
